Zoetis Inc. Unamortized Debt Issuance Expense
Zoetis Inc. (ZTS) had Unamortized Debt Issuance Expense of $17.00 million as of 2015-12-31, per its 10-K filed 2016-02-24.
Discontinued › Balance Sheet › Assets
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2016-02-24
- 2015-12-31: Unamortized Debt Issuance Expense $17.00M.
- 2015-09-27: Unamortized Debt Issuance Expense $17.00M.
- 2015-06-28: Unamortized Debt Issuance Expense $18.00M.
- 2015-03-29: Unamortized Debt Issuance Expense $18.00M.
| Period end | Unamortized Debt Issuance Expense |
|---|---|
| 2015-12-31 | $17.00M 10-K · filed 2016-02-24 |
| 2015-09-27 | $17.00M 10-Q · filed 2015-11-05 |
| 2015-06-28 | $18.00M 10-Q · filed 2015-08-06 |
| 2015-03-29 | $18.00M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $19.00M 10-K · filed 2016-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |